OXAZ-1

• CAT Number: I034044
• Molecular Formula: C26H28N2O6S
• Molecular Weight: 496.58
• Purity: 98%
• Synonyms: OXAZ-1; OXAZ 1; OXAZ1
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: methyl 2-[(3S,7R,8aS)-3-[[1-(4-methylphenyl)sulfonylindol-3-yl]methyl]-5-oxo-2,3,6,7,8,8a-hexahydro-[1,3]oxazolo[3,2-a]pyridin-7-yl]acetate
• InChI: InChI=1S/C26H28N2O6S/c1-17-7-9-21(10-8-17)35(31,32)27-15-19(22-5-3-4-6-23(22)27)14-20-16-34-25-12-18(13-26(30)33-2)11-24(29)28(20)25/h3-10,15,18,20,25H,11-14,16H2,1-2H3/t18-,20-,25-/m0/s1
• InChIKey: KKKPXGBKMQTDTR-KHOMTPLRSA-N
• SMILES: CC1=CC=C(C=C1)S(=O)(=O)N2C=C(C3=CC=CC=C32)C[C@H]4CO[C@@H]5N4C(=O)C[C@@H](C5)CC(=O)OC

OXAZ-1（Cat No.:I034044）is a small molecule compound that has been investigated for its potential as a therapeutic agent, particularly in the context of neurodegenerative diseases and cancer. It is known to exhibit neuroprotective and anti-inflammatory properties, which may be beneficial in conditions such as Alzheimer’s disease, Parkinson’s disease, or other disorders involving oxidative stress and neuronal damage. OXAZ-1 has been shown to influence cellular pathways related to apoptosis, oxidative stress, and inflammation. However, further preclinical and clinical studies are needed to fully evaluate its safety, efficacy, and potential applications in various therapeutic areas.